Stigma toward those with non-medical substance use may present as anticipated, perceived, enacted, or internalized stigma.
Objective:
The purpose of the study was to describe the role of stigma on health care professionals with non-medical substance use, from the perspective of treatment providers. Soliciting information about stigma from treatment providers is a unique perspective lacking in current literature.
Methods:
A qualitative descriptive design was used with semi-structured interviews of treatment providers (N = 16) in Colorado. Inductive content analysis was used to identify concepts and themes across interviews.
Results:
Findings showed that stigma is a major concern and a barrier for health care professionals seeking substance use treatment. Nurses and physicians demonstrate shame and guilt (internalized stigma) around their substance use. These professionals also experience fear around their reputation (perceived stigma) and challenges around re-entry to the workforce after treatment (anticipated stigma).
Conclusions:
The awareness of existing stigma as well as internalized stigma impacts how health care professionals approach treatment, recovery, and returning to work.
MartinsSSGhandourLA. Nonmedical use of prescription drugs in adolescents and young adults: not just a western phenomenon. World Psychiatry. 2017;16:102-104.
2.
Substance Abuse and Mental Health Services Administration. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Department of Health and Human Services; 2016.
3.
BaldisseriMR. The impaired healthcare professional. Crit Care Med. 2007;35:S106-S116.
4.
MerloLJTrejo-LopezJConwellTRivenbarkJ. Patterns of substance use initiation among healthcare professionals in recovery. Am J Addict. 2013;22(6):605-612.
5.
PaceEMKestersonCGarciaKDeniousJFinnellDSBaylessSD. Experiences and outcomes of nurses referred to a peer health assistance program: recommendations for nursing management. J Nurs Manag. 2020;28(1):35-42.
6.
BrooksEEarlySRGundersenDCShoreJHGendelMH. Comparing substance use monitoring and treatment variations among physician health programs. Am J Addict. 2012;21(4):327-334.
7.
BergeKHDillonKRSikkinkKMTaylorTKLanierWL. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Mayo Clin Proc. 2012;87(7):674-682.
8.
Centers for Disease Control and Prevention. Hepatitis C virus potentially transmitted by opioid drug diversion from a nurse—Washington, August 2017—March 2018. Morbidity and Mortality Weekly Report. Published April26, 2019. Accessed April 20, 2021. https://www.cdc.gov/mmwr/volumes/68/wr/mm6816a3.htm
9.
BiancarelliDLBielloKBChildsE, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;19:80-86.
10.
Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019. Accessed April 20, 2021. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health
11.
GunnAJSacksTKJemalA. “That’s not me anymore”: resistance strategies for managing intersectional stigmas for women with substance use and incarceration histories. Qual Soc Work. 2018;17(4):490-508.
12.
ReyCNKurtiANBadgerGJCohenAHHeilSH. Stigma, discrimination, treatment effectiveness, and policy support: comparing behavior analysts’ views on drug addiction and mental illness. Behav Anal Pract. 2019;12(4):758-766.
13.
YangLHWongLYGrivelMMHasinDS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30(5):378-388.
14.
Des JarlaisDC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J. 2017;14:1-7.
15.
RoomR. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143-155.
16.
GoodyearKHaass-KofflerCLChavanneD. Opioid use and stigma: the role of gender, language and precipitating events. Drug Alcohol Depend. 2018;185:339-346.
17.
ScamblerG. Health-related stigma. Sociol Health Illn. 2009;31:441-455.
18.
van BrakelWHCataldoJGroverS, et al. Out of the silos: identifying cross-cutting features of health-related stigma to advance measurement and intervention. BMC Med. 2019;17:1-17.
19.
GoffmanE. Stigma: Notes on the Management of Spoiled Identity. Simon & Schuster; 1963.
20.
CorriganPWNieweglowskiK. Stigma and the public agenda for the opioid crisis in America. Int J Drug Policy. 2018;59:44-49.
21.
CooperSCampbellGLaranceBMurnionBNielsenS. Perceived stigma and social support in treatment for pharmaceutical opioid dependence. Drug Alcohol Rev. 2018;37(2):262-272.
22.
NybladeLStocktonMAGigerK, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17(25):1-15.
23.
PaquetteCESyvertsenJLPolliniRA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104-110.
24.
BirtelMDWoodLKempaNJ. Stigma and social support in substance abuse: implications for mental health and well-being. Psychiatry Res. 2017;252:1-8.
25.
McCraddenMDVasilevaDOrchanian-CheffABuchmanDZ. Ambiguous identifies of drugs and people: a scoping review of opioid-related stigma. Int J Drug Policy. 2019;74:205-215.
26.
ChaudoirSREarnshawVAAndelS. “Discredited” versus “discreditable”: understanding how shared and unique stigma mechanisms affect psychological and physical health disparities. Basic Appl Soc Psych. 2013;35:75-87.
27.
HatzenbuehlerML. Structural stigma: research evidence and implications for psychological science. Am Psychol. 2016;71(8):742-751.
28.
CrapanzanoKAHammarlundRAhmadBHunsingerNKullarR. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 2019;10:1-12.
29.
McGintyEEStoneEMKennedy-HendricksABarryCL. Stigmatizing language in news media coverage of the opioid epidemic: implications for public health. Prev Med. 2019;124:110-114.
30.
BarryCLMcGintyEEPescosolidoBAGoldmanHH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv. 2014;65(10):1269-1272.
31.
PattonMQ. Qualitative Evaluation and Research Methods. Sage; 2015.
32.
DoyleLMcCabeCKeoghBBradyAMcCannM. An overview of the qualitative descriptive design within nursing research. J Res Nurs. 2020;25:443-455.
33.
KimHSefcikJSBradwayC. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2018;40:23-42.
34.
SandelowskiM. Whatever happened to qualitative description?Res Nurs Health. 2000;23(4):334-340.
Rev. Convert audio and video to text. Date unknown. Accessed July 20, 2023. https://www.rev.com/
37.
GraneheimUHLundmanB. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105-112.
38.
VaismoradiMTurunenHBondasT. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398-405.
39.
EloSKyngasH. The qualitative content analysis process. J Adv Nurs. 2007;62:107-115.
40.
Sociocultural Research Consultants, Inc. Dedoose (Version 9.0.15). Published 2019. Accessed July 20, 2023. www.dedoose.com
41.
LincolnYSGubaEG. But is it rigorous? trustworthiness and authenticity in naturalistic evaluation. Naturalistic Eval. 1986;30:73-84.
42.
RossCAJakubecSLBerryNSSmyeV. “A two glass of wine shift”: dominant discourses and the social organization of nurses’ substance use. Glob Qual Nurs Res. 2018;5:2333393618810655.
43.
LivingstonJDMilneTFangMLAmariE. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2011;107:39-50.
